Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-3-13
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1087-0156
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9447582-Angiotensin II,
pubmed-meshheading:9447582-Blood Pressure,
pubmed-meshheading:9447582-Genotype,
pubmed-meshheading:9447582-Humans,
pubmed-meshheading:9447582-Hypertension,
pubmed-meshheading:9447582-Life Style,
pubmed-meshheading:9447582-Pharmacogenetics,
pubmed-meshheading:9447582-Risk Factors,
pubmed-meshheading:9447582-Sodium, Dietary
|
pubmed:year |
1998
|
pubmed:articleTitle |
Myriad's lifestyle test targets borderline hypertensives.
|
pubmed:publicationType |
News
|